2.77 USD
↗ 0.13 (4.92%)AT CLOSE (11:59 AM EDT)
Protalix BioTherapeutics, Inc. Common Stock
PLXAMEX • USD
2.78
↗ 0.01 (0.52%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
2.78
↗ 0.01 (0.52%)
Market: CLOSED
Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $2.77. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 14, 2026.
Open?$2.63
High?$2.79
Low?$2.62
Prev. Close?$2.64
Volume?952.1K
Avg. Volume?799.4K
VWAP?$2.74
Rel. Volume?1.19x
Bid / Ask
Bid?$2.75 × 1.0K
Ask?$2.79 × 200
Spread?$0.04
Midpoint?$2.77
Valuation & Ratios
Market Cap?212.7M
Shares Out?80.6M
Float?75.0M
Float %?93.1%
P/E Ratio?11.23
P/B Ratio?2.98
EPS?$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Employees
226
Market Cap
212.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1996-01-02
Address
2 UNIVERSITY PLAZA
HACKENSACK, NJ 07601
Phone: 201-696-9345
HACKENSACK, NJ 07601
Phone: 201-696-9345
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?35
Short Sent.?74
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.37Safe
Confidence?53%Low
Short InterestModerate
Short % of Float?4.22%Low
Short Interest?3.2M
Days to Cover?4.8
Free Float75.0M
Avg Daily Volume666.4K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.94Strong
Quick Ratio?1.91Adequate
Cash Ratio?0.87Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score94/100
P/E?11.2CHEAP▾
Peers100
S&P93
P/B?2.98CHEAP▾
Peers100
S&P56
P/S?2.64CHEAP▾
Peers100
S&P55
P/FCF?27.7FAIR▾
Peers100
S&P33
EV/EBITDA?7.5CHEAP▾
Peers100
S&P93
EV/Sales?2.30CHEAP▾
Peers100
S&P70
Returns & Efficiency
ROE?26.5%STRONG▾
Peers50
S&P76
ROA?17.2%STRONG▾
Peers50
S&P91
Cash Flow & Enterprise
FCF?$7.7M
Enterprise Value?$185.3M
Fundamentals ratios updated end of day